Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polypeptides and nucleic acids for treating ErbB2-dependent cancers

Polypeptides and nucleic acids for treating ErbB2-dependent cancers

US Patent 9127077 · Granted Sep 8, 2015

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnosis and/or prognosis of HER2-dependent cancer using one or more miRNA as a2023
Treatment of HER-2 dependent cancer using an agent that modulates the activity o2022
Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibi2020
CD147 as receptor for pilus-mediated adhesion of Meningococci to vascular endoth2018